aclarubicin - CISMeF

Preferred Label : aclarubicin;

MeSH definition : An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.;

MeSH synonym : aclacinomycin a;

CISMeF synonym : lundbeck brand of aclarubicin hydrochloride; medac brand of aclarubicin hydrochloride;

MeSH hyponym : NSC-208734; MA-144A1; aclacin; aclaplastin; NSC 208734; NSC208734; MA 144A1; MA144A1;

MeSH CAS label : 1-Naphthacenecarboxylic acid,(2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, methyl ester, (1R-(1alpha,2beta,4beta))-;

MeSH Related Number : 57576-44-0 (Aclarubicin);

Registry Number MeSH : 57576-44-0;

Wikipedia link : https://en.wikipedia.org/wiki/Aclarubicin;

Codes EINECS : 260-824-3;

Is substance : O;

UNII : 74KXF8I502;

InChIKey : USZYSDMBJDPRIF-SVEJIMAYSA-N;

Details

Origin ID

D015250;

UMLS CUI

C0001143;

ATC code(s)
- aclarubicin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Aclacinomycin Antitumor Antibiotic [NCIt concept]
- Aclarubicin [ICHI extension code]
CISMeF manual mappings
- Aclarubicin poisoning (disorder) [SNOMED CT concept]
- aclarubicin [Substance BNPC]
Pharmacological action(s)
- antibiotics, antineoplastic [MeSH Descriptor]
- enzyme inhibitors [MeSH Descriptor]
- topoisomerase II inhibitors [MeSH Descriptor]
Record concept(s)
- MA-144A1 [MeSH concept]
- NSC-208734 [MeSH concept]
- aclacin [MeSH concept]
- aclaplastin [MeSH concept]
- aclarubicin [MeSH concept]
Related MeSH Supplementary Concept(s)
- 10-decarboxymethylaclacinomycin T [MeSH Supplementary Concept]
- 11-hydroxyaclacinomycin A [MeSH Supplementary Concept]
- 11-hydroxyaclacinomycin X [MeSH Supplementary Concept]
- 15-demethoxyaclacinomycin T [MeSH Supplementary Concept]
- 2-hydroxyaclacinomycin A [MeSH Supplementary Concept]
- 2-hydroxyaclacinomycin B [MeSH Supplementary Concept]
- 4-O-methylaclacinomycin [MeSH Supplementary Concept]
- 6-O-methylaclacinomycin [MeSH Supplementary Concept]
- AB-triple V protocol [MeSH Supplementary Concept]
- ABEP protocol 1 [MeSH Supplementary Concept]
- AclBEP protocol [MeSH Supplementary Concept]
- BGM 84 protocol [MeSH Supplementary Concept]
- BH-AC-AMP protocol [MeSH Supplementary Concept]
- BHAC-AMP protocol [MeSH Supplementary Concept]
- CAG protocol [MeSH Supplementary Concept]
- CAOP protocol [MeSH Supplementary Concept]
- CAP therapy protocol [MeSH Supplementary Concept]
- N-allyl-aclacinomycin A [MeSH Supplementary Concept]
- N-benzyl-aclacinomycin A [MeSH Supplementary Concept]
- aclacinomycins [MeSH Supplementary Concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Aclarubicin [ICD-11 Extension code]
- Aclarubicin [NCIt concept]
- Aclarubicin (substance) [SNOMED CT concept]
- Product containing aclarubicin (medicinal product) [SNOMED CT concept]
- aclarubicin [ATC Code]
Validated automatic mappings to BTNT
- Aclarubicin Hydrochloride [NCIt concept]
- aclarubicin [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients